Joseph Gonzalez-Heydrich, M.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Psychotic Disorders | 17 | 2024 | 3219 | 2.040 |
Why?
|
| Evoked Potentials, Auditory | 4 | 2019 | 531 | 1.410 |
Why?
|
| Methylphenidate | 5 | 2014 | 488 | 1.240 |
Why?
|
| Epilepsy | 12 | 2021 | 3304 | 1.140 |
Why?
|
| Schizophrenia | 8 | 2023 | 6929 | 1.120 |
Why?
|
| Central Nervous System Stimulants | 6 | 2014 | 1176 | 0.960 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 10 | 2014 | 3707 | 0.950 |
Why?
|
| DNA Copy Number Variations | 4 | 2022 | 2024 | 0.670 |
Why?
|
| Valproic Acid | 3 | 2008 | 443 | 0.650 |
Why?
|
| Suicidal Ideation | 4 | 2018 | 1447 | 0.620 |
Why?
|
| Propylamines | 2 | 2010 | 161 | 0.610 |
Why?
|
| Event-Related Potentials, P300 | 1 | 2019 | 149 | 0.590 |
Why?
|
| Carbamazepine | 2 | 2006 | 224 | 0.510 |
Why?
|
| Risperidone | 3 | 2008 | 381 | 0.490 |
Why?
|
| Neurophysiology | 1 | 2015 | 144 | 0.480 |
Why?
|
| Chromosomes, Human, Pair 16 | 1 | 2016 | 343 | 0.460 |
Why?
|
| Child | 51 | 2024 | 80134 | 0.460 |
Why?
|
| Adaptation, Psychological | 9 | 2021 | 2632 | 0.440 |
Why?
|
| Social Support | 5 | 2022 | 2175 | 0.440 |
Why?
|
| Point Mutation | 1 | 2018 | 1593 | 0.430 |
Why?
|
| Amphetamine | 1 | 2014 | 224 | 0.420 |
Why?
|
| Adolescent | 43 | 2024 | 88271 | 0.410 |
Why?
|
| Suicide, Attempted | 3 | 2018 | 1402 | 0.400 |
Why?
|
| Adrenergic Uptake Inhibitors | 2 | 2010 | 186 | 0.400 |
Why?
|
| Anticonvulsants | 5 | 2010 | 1911 | 0.390 |
Why?
|
| Developmental Disabilities | 2 | 2021 | 1510 | 0.380 |
Why?
|
| Cerebral Cortex | 2 | 2019 | 5777 | 0.370 |
Why?
|
| Antipsychotic Agents | 6 | 2011 | 3063 | 0.340 |
Why?
|
| Adrenocorticotropic Hormone | 3 | 2001 | 618 | 0.330 |
Why?
|
| Obsessive-Compulsive Disorder | 1 | 2018 | 1492 | 0.330 |
Why?
|
| Rage | 1 | 2009 | 30 | 0.320 |
Why?
|
| Adaptation, Physiological | 1 | 2016 | 1301 | 0.320 |
Why?
|
| Internet | 3 | 2010 | 3094 | 0.320 |
Why?
|
| Language | 1 | 2018 | 1538 | 0.320 |
Why?
|
| Aggression | 4 | 2007 | 748 | 0.310 |
Why?
|
| Movement Disorders | 1 | 2012 | 459 | 0.310 |
Why?
|
| Adaptor Proteins, Signal Transducing | 1 | 2018 | 2892 | 0.300 |
Why?
|
| Pediatrics | 5 | 2009 | 3589 | 0.300 |
Why?
|
| Emotional Intelligence | 1 | 2009 | 135 | 0.290 |
Why?
|
| Psychotropic Drugs | 2 | 2012 | 885 | 0.280 |
Why?
|
| Neuronal Plasticity | 1 | 2016 | 1433 | 0.280 |
Why?
|
| Mianserin | 1 | 2007 | 51 | 0.280 |
Why?
|
| Autistic Disorder | 1 | 2016 | 1222 | 0.260 |
Why?
|
| Pirenzepine | 2 | 2003 | 116 | 0.260 |
Why?
|
| Antidepressive Agents, Tricyclic | 1 | 2007 | 431 | 0.240 |
Why?
|
| Phobic Disorders | 1 | 2007 | 439 | 0.230 |
Why?
|
| Mental Disorders | 6 | 2022 | 6818 | 0.230 |
Why?
|
| Electroencephalography | 6 | 2019 | 6242 | 0.220 |
Why?
|
| Nuclear Proteins | 1 | 2018 | 5781 | 0.220 |
Why?
|
| Narration | 1 | 2006 | 218 | 0.220 |
Why?
|
| Fragile X Syndrome | 2 | 2017 | 116 | 0.220 |
Why?
|
| Child, Preschool | 17 | 2024 | 42217 | 0.220 |
Why?
|
| Hydrocortisone | 3 | 2001 | 1818 | 0.220 |
Why?
|
| Periodicals as Topic | 1 | 2014 | 1463 | 0.220 |
Why?
|
| Male | 42 | 2024 | 360675 | 0.210 |
Why?
|
| Seizures | 2 | 2007 | 2965 | 0.210 |
Why?
|
| Humans | 71 | 2024 | 761098 | 0.210 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2003 | 411 | 0.200 |
Why?
|
| Aspartate Aminotransferases | 1 | 2003 | 411 | 0.200 |
Why?
|
| Somatosensory Disorders | 1 | 2022 | 49 | 0.190 |
Why?
|
| Depressive Disorder, Major | 2 | 2019 | 4766 | 0.190 |
Why?
|
| Somatoform Disorders | 1 | 2024 | 423 | 0.190 |
Why?
|
| Risk | 3 | 2019 | 9614 | 0.190 |
Why?
|
| Hallucinations | 1 | 2024 | 366 | 0.190 |
Why?
|
| Acoustic Stimulation | 2 | 2016 | 1235 | 0.190 |
Why?
|
| Bipolar Disorder | 3 | 2008 | 5091 | 0.180 |
Why?
|
| Alanine Transaminase | 1 | 2003 | 602 | 0.180 |
Why?
|
| Self-Help Groups | 2 | 2001 | 192 | 0.170 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2001 | 361 | 0.170 |
Why?
|
| Adaptor Proteins, Vesicular Transport | 1 | 2021 | 303 | 0.170 |
Why?
|
| Receptors, Serotonin | 2 | 1991 | 208 | 0.170 |
Why?
|
| Antimanic Agents | 1 | 2003 | 520 | 0.170 |
Why?
|
| Organ Transplantation | 1 | 2010 | 1164 | 0.170 |
Why?
|
| Spastic Paraplegia, Hereditary | 1 | 2022 | 168 | 0.160 |
Why?
|
| Quarantine | 1 | 2021 | 182 | 0.160 |
Why?
|
| Female | 38 | 2024 | 392458 | 0.160 |
Why?
|
| International Classification of Diseases | 1 | 2024 | 913 | 0.160 |
Why?
|
| Child Abuse, Sexual | 1 | 2001 | 403 | 0.160 |
Why?
|
| Depressive Disorder | 2 | 2015 | 3727 | 0.160 |
Why?
|
| Psychopharmacology | 1 | 2000 | 144 | 0.160 |
Why?
|
| Sodium-Potassium-Exchanging ATPase | 1 | 2021 | 476 | 0.150 |
Why?
|
| Pain | 2 | 2024 | 5070 | 0.150 |
Why?
|
| Phenotype | 5 | 2021 | 16572 | 0.140 |
Why?
|
| Psychotherapy | 3 | 2015 | 1646 | 0.140 |
Why?
|
| Social Behavior Disorders | 1 | 2017 | 96 | 0.140 |
Why?
|
| Social Perception | 2 | 2017 | 431 | 0.130 |
Why?
|
| Writing | 1 | 1998 | 199 | 0.130 |
Why?
|
| Discriminant Analysis | 1 | 2015 | 223 | 0.130 |
Why?
|
| DiGeorge Syndrome | 1 | 2017 | 185 | 0.120 |
Why?
|
| Theory of Mind | 1 | 2017 | 91 | 0.120 |
Why?
|
| Drugs, Investigational | 1 | 2017 | 212 | 0.120 |
Why?
|
| User-Computer Interface | 4 | 2003 | 1395 | 0.120 |
Why?
|
| Pituitary-Adrenal System | 2 | 1999 | 551 | 0.120 |
Why?
|
| Comparative Genomic Hybridization | 1 | 2016 | 473 | 0.120 |
Why?
|
| Psychiatric Status Rating Scales | 4 | 2015 | 6011 | 0.120 |
Why?
|
| Software | 5 | 2010 | 4433 | 0.110 |
Why?
|
| Parents | 2 | 2006 | 3564 | 0.110 |
Why?
|
| Medical Records Systems, Computerized | 1 | 2000 | 1191 | 0.110 |
Why?
|
| Antidepressive Agents | 1 | 2006 | 2893 | 0.110 |
Why?
|
| Auditory Perception | 1 | 2019 | 583 | 0.110 |
Why?
|
| Hypothalamo-Hypophyseal System | 2 | 1999 | 700 | 0.110 |
Why?
|
| Uncertainty | 1 | 2019 | 752 | 0.110 |
Why?
|
| Mendelian Randomization Analysis | 1 | 2018 | 1010 | 0.100 |
Why?
|
| Child Abuse | 1 | 2022 | 1076 | 0.100 |
Why?
|
| Principal Component Analysis | 1 | 2015 | 942 | 0.100 |
Why?
|
| Severity of Illness Index | 6 | 2024 | 15845 | 0.100 |
Why?
|
| Baclofen | 1 | 2012 | 120 | 0.100 |
Why?
|
| Age of Onset | 1 | 2018 | 3307 | 0.100 |
Why?
|
| Adult | 17 | 2024 | 221083 | 0.090 |
Why?
|
| Drug Interactions | 2 | 2008 | 1417 | 0.090 |
Why?
|
| Chromosome Deletion | 1 | 2016 | 1386 | 0.090 |
Why?
|
| Protein Conformation | 1 | 2018 | 3936 | 0.090 |
Why?
|
| Child Behavior | 1 | 2016 | 848 | 0.090 |
Why?
|
| Caregivers | 1 | 2022 | 2241 | 0.090 |
Why?
|
| Models, Neurological | 2 | 2022 | 1768 | 0.090 |
Why?
|
| Neurotransmitter Uptake Inhibitors | 1 | 1990 | 36 | 0.090 |
Why?
|
| Odds Ratio | 1 | 2022 | 9648 | 0.090 |
Why?
|
| Family | 1 | 2021 | 3193 | 0.090 |
Why?
|
| Caudate Nucleus | 1 | 1991 | 390 | 0.080 |
Why?
|
| Personality | 1 | 1993 | 553 | 0.080 |
Why?
|
| Evoked Potentials | 1 | 2016 | 1047 | 0.080 |
Why?
|
| Behavior | 1 | 2012 | 540 | 0.080 |
Why?
|
| Comorbidity | 5 | 2017 | 10514 | 0.080 |
Why?
|
| Nervous System | 1 | 2012 | 545 | 0.080 |
Why?
|
| Models, Psychological | 1 | 1993 | 828 | 0.080 |
Why?
|
| Inflammatory Bowel Diseases | 2 | 2014 | 2423 | 0.080 |
Why?
|
| Models, Molecular | 1 | 2018 | 5413 | 0.080 |
Why?
|
| Emotions | 2 | 2017 | 2740 | 0.070 |
Why?
|
| Vomiting | 1 | 1991 | 651 | 0.070 |
Why?
|
| Adolescent Behavior | 1 | 2016 | 1188 | 0.070 |
Why?
|
| Liver | 1 | 2003 | 7513 | 0.070 |
Why?
|
| Retrospective Studies | 8 | 2014 | 80673 | 0.070 |
Why?
|
| Circadian Rhythm | 1 | 1999 | 2570 | 0.070 |
Why?
|
| Electronic Health Records | 1 | 2024 | 4813 | 0.070 |
Why?
|
| Amphetamines | 1 | 2007 | 143 | 0.070 |
Why?
|
| Analysis of Variance | 1 | 2015 | 6224 | 0.070 |
Why?
|
| Hyperkinesis | 1 | 2007 | 89 | 0.070 |
Why?
|
| Child Development Disorders, Pervasive | 1 | 2011 | 600 | 0.070 |
Why?
|
| Genetic Association Studies | 1 | 2016 | 2731 | 0.070 |
Why?
|
| Neurology | 1 | 2014 | 784 | 0.070 |
Why?
|
| Diagnosis, Differential | 3 | 2019 | 12975 | 0.070 |
Why?
|
| Personality Assessment | 1 | 2008 | 649 | 0.070 |
Why?
|
| Gene Expression | 1 | 2018 | 7567 | 0.060 |
Why?
|
| Intelligence Tests | 1 | 2007 | 503 | 0.060 |
Why?
|
| Pilot Projects | 5 | 2024 | 8639 | 0.060 |
Why?
|
| Linear Models | 1 | 2015 | 5869 | 0.060 |
Why?
|
| Serotonin | 1 | 1990 | 1043 | 0.060 |
Why?
|
| Medical Records | 1 | 2010 | 1409 | 0.060 |
Why?
|
| Child Development | 1 | 2017 | 2302 | 0.060 |
Why?
|
| Computer Simulation | 2 | 1999 | 6225 | 0.060 |
Why?
|
| Confidence Intervals | 1 | 2010 | 2927 | 0.060 |
Why?
|
| Affective Symptoms | 1 | 2007 | 417 | 0.060 |
Why?
|
| Neuropsychological Tests | 2 | 2014 | 7043 | 0.060 |
Why?
|
| Genotype | 1 | 2018 | 12983 | 0.060 |
Why?
|
| Cross-Over Studies | 1 | 2010 | 2081 | 0.060 |
Why?
|
| Hemodialysis Units, Hospital | 1 | 2003 | 22 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2007 | 2855 | 0.050 |
Why?
|
| Depression | 2 | 2014 | 8130 | 0.050 |
Why?
|
| Treatment Outcome | 7 | 2017 | 64670 | 0.050 |
Why?
|
| Genetic Linkage | 1 | 2008 | 2340 | 0.050 |
Why?
|
| Attitude to Computers | 2 | 2001 | 195 | 0.050 |
Why?
|
| Feasibility Studies | 3 | 2010 | 5249 | 0.050 |
Why?
|
| Crohn Disease | 1 | 2015 | 2279 | 0.050 |
Why?
|
| Cohort Studies | 2 | 2022 | 41486 | 0.050 |
Why?
|
| Interpersonal Relations | 1 | 2010 | 1437 | 0.050 |
Why?
|
| Mutation | 3 | 2022 | 30006 | 0.050 |
Why?
|
| Psychiatry | 1 | 2014 | 1692 | 0.050 |
Why?
|
| Models, Biological | 2 | 1999 | 9455 | 0.050 |
Why?
|
| Synapses | 1 | 1991 | 1755 | 0.050 |
Why?
|
| Calpain | 1 | 2022 | 146 | 0.050 |
Why?
|
| Safety | 1 | 2006 | 1151 | 0.050 |
Why?
|
| Catastrophization | 1 | 2024 | 349 | 0.050 |
Why?
|
| Computers | 1 | 2003 | 591 | 0.040 |
Why?
|
| Mothers | 2 | 2001 | 2193 | 0.040 |
Why?
|
| Age Factors | 2 | 2007 | 18385 | 0.040 |
Why?
|
| Benzodiazepines | 2 | 2003 | 1134 | 0.040 |
Why?
|
| Young Adult | 4 | 2024 | 59199 | 0.040 |
Why?
|
| Parvalbumins | 1 | 2021 | 260 | 0.040 |
Why?
|
| Biomedical Technology | 1 | 2002 | 210 | 0.040 |
Why?
|
| Neurons | 2 | 2021 | 9435 | 0.040 |
Why?
|
| Genes, Dominant | 1 | 2021 | 850 | 0.040 |
Why?
|
| Psychopathology | 1 | 2022 | 432 | 0.040 |
Why?
|
| Prospective Studies | 4 | 2015 | 54419 | 0.040 |
Why?
|
| Social Behavior | 2 | 2017 | 1135 | 0.040 |
Why?
|
| Gastrointestinal Diseases | 1 | 2007 | 1201 | 0.040 |
Why?
|
| Hypermedia | 1 | 1998 | 20 | 0.040 |
Why?
|
| Drug Administration Schedule | 1 | 2006 | 4849 | 0.040 |
Why?
|
| Therapy, Computer-Assisted | 1 | 2000 | 266 | 0.040 |
Why?
|
| Multimedia | 1 | 1998 | 75 | 0.040 |
Why?
|
| Neocortex | 1 | 2021 | 416 | 0.040 |
Why?
|
| Risk Assessment | 2 | 2024 | 24013 | 0.040 |
Why?
|
| Body Weight | 1 | 2008 | 4618 | 0.040 |
Why?
|
| Child Behavior Disorders | 1 | 2002 | 804 | 0.030 |
Why?
|
| Brain | 3 | 2021 | 27097 | 0.030 |
Why?
|
| Cognition | 1 | 2014 | 6987 | 0.030 |
Why?
|
| Interneurons | 1 | 2021 | 587 | 0.030 |
Why?
|
| Pancreatitis | 1 | 2003 | 1097 | 0.030 |
Why?
|
| Mother-Child Relations | 1 | 2000 | 495 | 0.030 |
Why?
|
| Double-Blind Method | 1 | 2010 | 12341 | 0.030 |
Why?
|
| Complementary Therapies | 1 | 1999 | 486 | 0.030 |
Why?
|
| Disabled Children | 1 | 1998 | 251 | 0.030 |
Why?
|
| Qualitative Research | 1 | 2006 | 3016 | 0.030 |
Why?
|
| Risk Factors | 4 | 2022 | 74219 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2007 | 10755 | 0.030 |
Why?
|
| Renal Dialysis | 2 | 2002 | 1796 | 0.030 |
Why?
|
| Pedigree | 1 | 2022 | 4537 | 0.030 |
Why?
|
| Heart Defects, Congenital | 2 | 2001 | 4673 | 0.030 |
Why?
|
| Fetus | 1 | 2021 | 1862 | 0.030 |
Why?
|
| Monte Carlo Method | 1 | 1999 | 1257 | 0.030 |
Why?
|
| Signal Transduction | 1 | 2016 | 23415 | 0.030 |
Why?
|
| Hospitals, Pediatric | 1 | 2002 | 1860 | 0.030 |
Why?
|
| Mutation, Missense | 1 | 2021 | 2567 | 0.030 |
Why?
|
| Chronic Disease | 3 | 2000 | 9317 | 0.030 |
Why?
|
| Case-Control Studies | 2 | 2018 | 22157 | 0.020 |
Why?
|
| Kidney Failure, Chronic | 2 | 2002 | 2478 | 0.020 |
Why?
|
| Giardiasis | 1 | 1991 | 28 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2024 | 20120 | 0.020 |
Why?
|
| Internal-External Control | 1 | 2012 | 358 | 0.020 |
Why?
|
| Esophageal Achalasia | 1 | 1991 | 94 | 0.020 |
Why?
|
| Stomach Diseases | 1 | 1991 | 134 | 0.020 |
Why?
|
| Gene Expression Regulation, Developmental | 1 | 2021 | 3598 | 0.020 |
Why?
|
| Single-Cell Analysis | 1 | 2021 | 2452 | 0.020 |
Why?
|
| Child, Hospitalized | 2 | 2002 | 182 | 0.020 |
Why?
|
| Genetic Testing | 1 | 2023 | 3536 | 0.020 |
Why?
|
| Family Therapy | 1 | 1991 | 214 | 0.020 |
Why?
|
| Serotonin Antagonists | 1 | 1990 | 144 | 0.020 |
Why?
|
| Gastric Emptying | 1 | 1991 | 243 | 0.020 |
Why?
|
| Personality Disorders | 1 | 1993 | 719 | 0.020 |
Why?
|
| Lod Score | 1 | 2008 | 600 | 0.020 |
Why?
|
| Middle Aged | 5 | 2024 | 220835 | 0.020 |
Why?
|
| Tissue Distribution | 1 | 1991 | 2262 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 8 | 1 | 2008 | 452 | 0.020 |
Why?
|
| Parent-Child Relations | 1 | 1991 | 762 | 0.020 |
Why?
|
| RNA, Messenger | 1 | 2021 | 12743 | 0.020 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2015 | 1878 | 0.020 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2007 | 17889 | 0.020 |
Why?
|
| Siblings | 1 | 2008 | 824 | 0.010 |
Why?
|
| Huntington Disease | 1 | 1991 | 1145 | 0.010 |
Why?
|
| Algorithms | 1 | 2024 | 14023 | 0.010 |
Why?
|
| Reference Values | 1 | 1991 | 4922 | 0.010 |
Why?
|
| Learning | 1 | 1993 | 1739 | 0.010 |
Why?
|
| Synaptic Transmission | 1 | 1990 | 1169 | 0.010 |
Why?
|
| Databases, Factual | 1 | 1999 | 7969 | 0.010 |
Why?
|
| Activities of Daily Living | 1 | 2012 | 2420 | 0.010 |
Why?
|
| Binding Sites | 1 | 1991 | 5993 | 0.010 |
Why?
|
| Adolescent, Hospitalized | 1 | 2002 | 30 | 0.010 |
Why?
|
| Play and Playthings | 1 | 2002 | 85 | 0.010 |
Why?
|
| Animals | 2 | 2017 | 168083 | 0.010 |
Why?
|
| Nerve Net | 1 | 1993 | 2290 | 0.010 |
Why?
|
| Interviews as Topic | 1 | 2008 | 2696 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2017 | 8000 | 0.010 |
Why?
|
| Brief Psychiatric Rating Scale | 1 | 2001 | 108 | 0.010 |
Why?
|
| Weight Gain | 2 | 2002 | 2349 | 0.010 |
Why?
|
| Infant, Newborn | 1 | 2021 | 26187 | 0.010 |
Why?
|
| Self Disclosure | 1 | 2002 | 249 | 0.010 |
Why?
|
| Video Games | 1 | 2003 | 197 | 0.010 |
Why?
|
| Prolactin | 1 | 2002 | 625 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2011 | 8519 | 0.010 |
Why?
|
| Evidence-Based Medicine | 1 | 2011 | 3689 | 0.010 |
Why?
|
| Infant | 1 | 2021 | 36164 | 0.010 |
Why?
|
| Computer Graphics | 1 | 2001 | 338 | 0.010 |
Why?
|
| Appetite | 1 | 2001 | 247 | 0.010 |
Why?
|
| Outpatient Clinics, Hospital | 1 | 2001 | 392 | 0.010 |
Why?
|
| Disorders of Excessive Somnolence | 1 | 2001 | 277 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 36418 | 0.010 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2011 | 10213 | 0.010 |
Why?
|
| Abdominal Pain | 1 | 2001 | 1071 | 0.010 |
Why?
|
| Forecasting | 1 | 2002 | 2928 | 0.010 |
Why?
|
| Follow-Up Studies | 1 | 2012 | 39121 | 0.010 |
Why?
|
| Patient Education as Topic | 1 | 2001 | 2316 | 0.010 |
Why?
|
| Patient Compliance | 1 | 2001 | 2687 | 0.010 |
Why?
|
| Polymorphism, Single Nucleotide | 1 | 2008 | 15915 | 0.010 |
Why?
|
| Boston | 1 | 2002 | 9324 | 0.000 |
Why?
|
| Heart Diseases | 1 | 2002 | 2795 | 0.000 |
Why?
|
| Neurosurgical Procedures | 1 | 1999 | 2067 | 0.000 |
Why?
|
| Patient Satisfaction | 1 | 2001 | 3450 | 0.000 |
Why?
|
| Attitude of Health Personnel | 1 | 2001 | 3882 | 0.000 |
Why?
|
| Aged, 80 and over | 1 | 1991 | 58946 | 0.000 |
Why?
|
| United States | 1 | 2012 | 72337 | 0.000 |
Why?
|
| Time Factors | 1 | 2001 | 39953 | 0.000 |
Why?
|
| Aged | 1 | 1991 | 169266 | 0.000 |
Why?
|